Kohei Motoshima
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
Journal: Cancer chemotherapy and pharmacology
Published: January 24, 2016
Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.
Journal: Japanese journal of clinical oncology
Published: April 02, 2014
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: December 25, 2013
A case of lung cancer pain relief and safe return home by strontium chloride
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 16, 2013
Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab.
Journal: Respirology case reports
Published: June 19, 2013
Phase II trial of erlotinib in patients with advanced non‑small‑cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.
Journal: Cancer chemotherapy and pharmacology
Published: April 11, 2013
Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.
Journal: Clinical lung cancer
Published: January 11, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026